A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics

BACKGROUND: Our previous randomized double-blind study showed that drinking hydrogen (H(2)) water for 48 weeks significantly improved the total Unified Parkinson’s Disease Rating Scale (UPDRS) score of Parkinson’s disease (PD) patients treated with levodopa. We aim to confirm this result using a ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoritaka, Asako, Abe, Takashi, Ohtsuka, Chigumi, Maeda, Tetsuya, Hirayama, Masaaki, Watanabe, Hirohisa, Saiki, Hidemoto, Oyama, Genko, Fukae, Jiro, Shimo, Yasushi, Hatano, Taku, Kawajiri, Sumihiro, Okuma, Yasuyuki, Machida, Yutaka, Miwa, Hideto, Suzuki, Chikako, Kazama, Asuka, Tomiyama, Masahiko, Kihara, Takeshi, Hirasawa, Motoyuki, Shimura, Hideki, Hattori, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865993/
https://www.ncbi.nlm.nih.gov/pubmed/27176725
http://dx.doi.org/10.1186/s12883-016-0589-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865993/
https://www.ncbi.nlm.nih.gov/pubmed/27176725
http://dx.doi.org/10.1186/s12883-016-0589-0

Ejemplares similares